Researchers from Rutgers Health and other institutions have discovered why a powerful leukemia drug eventually fails in most ...

Primary plasma cell leukemia (pPCL) is a rare and highly aggressive plasma cell malignancy, often associated with complex genetic abnormalities. There is currently no standard treatment regimens, and ...

Mid Valley High School grad Eddie Kaufman, a star on the baseball field and golf course, and among family and friends, died ...

October 12, 2025 - PORTERVILLE, Calif. — A cutting-edge cancer treatment that reprograms the body’s own immune cells saved a ...

Haplo-cord HCT offered improved 2-year OS (72.7% vs 61.0%) and DFS (67.0% vs 49.6%) compared with haplo HCT alone.

CAR T cells are patient-derived, genetically engineered immune cells. They are "living drugs" and constitute a milestone in modern medicine. Equipping T cells, a key cell type of the immune system, ...

Researchers from the Alliance for Clinical Trials in Oncology have found that two targeted immunotherapy drugs lead to high remission rates and long ...

Canonization of the Roman Catholic Saint Carlo shines a spotlight on the near cure of acute promyelocytic leukemia — a rare, ...